Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-Doc Trial in Node-Positive Early Breast Cancer
NCT02115204Phase 3Completed
- Sponsor
- Westdeutsche Studiengruppe
- Start
- Jun 2000
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in breast cancer, sponsored by Westdeutsche Studiengruppe. Started Jun 2000; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02115204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115204.